Poly-ADP-ribose polymerase inhibition reduces mesenteric injury after cardiopulmonary bypass

Thoracic and Cardiovascular Surgeon

Volumn 52, Issue 6, 2004, Pages 338-343

  Szabó, Gábor ^a   Seres, L ^a   Soos P ^a   Flechtenmacher, C ^a   Zsengeller Z ^b   Sack, F U ^a   Szabo C ^b   Hagl, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INOTEK CORPORATION   (United States)

Author keywords

Cardiopulmonary bypass; Mesenteric injury; Poly (ADP ribose) polymerase

Indexed keywords

ACETYLCHOLINE; CREATINE KINASE; LACTASE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG SELECTIVITY; ENDOTHELIUM; ENZYME INHIBITION; ENZYME RELEASE; HEMODYNAMICS; INTERMETHOD COMPARISON; MESENTERITIS; MESENTERY; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VASCULAR RESISTANCE; VASODILATATION; WEANING;

ACETYLCHOLINE; ANIMALS; CARDIOPULMONARY BYPASS; CREATINE KINASE; DISEASE MODELS, ANIMAL; DOGS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; LACTIC ACID; MESENTERIC ARTERY, SUPERIOR; MESENTERIC VEINS; NITROPRUSSIDE; POLY(ADP-RIBOSE) POLYMERASES; REGIONAL BLOOD FLOW; TIME FACTORS; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 10844240617     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-821274     Document Type: Article

References (20)

1. Wallace A, Lam HW, Nose PS et al. Changes in systolic and diastolic ventricular function with cold cardioplegic arrest in man. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Card Surg 1994; 9: 497-502
2. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676-692
3. Andrási TB, Buhmann V, Soós P et al. Mesenteric complications after hypothermic cardiopulmonary bypass with cardiac arrest: underlying mechanisms. Artificial Organs 2002; 26: 943-946
4. Byhahn C, Strouhal U, Martens S et al. Incidence of gastrointestinal complications in cardiopulmonary bypass patients. World J Surg 2001; 25: 1140-1144
5. Klempnauer J, Grothues F, Bektas H et al. Acute mesenteric ischemia following cardiac surgery. J Cardiovasc Surg 1997; 38: 639-643
6. Andrási TB, Soós P, Bakos G et al. L-arginine protects the mesenteric vascular circulation against cardiopulmonary bypass-induced vascular dysfunction. Surgery 2003; 134: 72-79
7. Virág L, Szabó C. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429
8. Szabó G, Liaudet L, Hagl S et al. Poly (ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res 2004; 61: 471-480
9. Szabó C, Zingarelli B, O'Connor M et al. DNA strand breakage, activation of poly-ADP ribosyl synthase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 1996; 93: 1753-1758
10. Szabó C, Cuzzocrea S, Zingarelli B et al. Endothelial dysfunction in a rat model of endotoxin shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997; 100: 723-735.
11. Szabó G, Buhmann V, Andrási TB et al. Poly-ADP-Ribose polymerase (PARP)-inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest. J Thorac Cardiovasc Surg 2003; 126: 651-658
12. Szabó G, Soós P, Bährle S et al. Role of poly (ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass. Eur J Cardiothorac Surg 2004; 25: 825-832
13. Szabó G, Bährle S, Stumpf N et al. Poly (ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 2002; 90: 100-106
14. Sack FU, Dollner R, Reidenbach B et al. Extracorporeal circulation induced microvascular perfusion injury of the small bowel. Eur Surg Res 2002; 34: 418-424
15. Sack FU, Reidenbach B, Schledt A et al. Dopexamine attenuates microvascular perfusion injury of the small bowel in pigs induced by extracorporeal circulation. Br J Anaesth 2002; 88: 841-847
16. Tofukuji M, Stahl GL, Metais C, Tomita M et al. Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a. Ann Thorac Surg 2000; 69: 799-807
17. Akata T, Yoshitake J, Nakashima M et al. Effects of protamine on vascular smooth muscle of rabbit mesenteric artery. Anesthesiology 1991; 75: 833-846
18. Ohri SK, Bowles CW, Mathie RT et al. Effects of cardiopulmonary bypass protocols on gut tissue oxygenation and blood flow. Ann Thorac Surg 1997; 64: 163-170
19. Cuzzocrea S, Zingarelli B, Constantino G et al. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 1997; 121: 1065-1074
20. Mazzon E, Dugo L, De Sarro A et al. Beneficial effects of GPI 6150, an inhibitor of poly (ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Shock 2002; 17: 222-227